These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21889518)

  • 1. The GABA system in anxiety and depression and its therapeutic potential.
    Möhler H
    Neuropharmacology; 2012 Jan; 62(1):42-53. PubMed ID: 21889518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.
    Thoeringer CK; Erhardt A; Sillaber I; Mueller MB; Ohl F; Holsboer F; Keck ME
    J Psychopharmacol; 2010 May; 24(5):733-43. PubMed ID: 19346277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Implications of GABAergic synapses in neuropsychiatry].
    Lloyd KG; Perrault G; Zivkovic B
    J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression.
    Cryan JF; Kaupmann K
    Trends Pharmacol Sci; 2005 Jan; 26(1):36-43. PubMed ID: 15629203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol.
    de Haas SL; Zoethout RW; Van Dyck K; De Smet M; Rosen LB; Murphy MG; Gottesdiener KM; Schoemaker RC; Cohen AF; van Gerven JM
    J Psychopharmacol; 2012 Feb; 26(2):282-91. PubMed ID: 21890585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of GABAA receptors in cognition.
    Möhler H
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1328-33. PubMed ID: 19909270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R
    Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing new treatments for depression and anxiety.
    Chen Z; Yang J; Tobak A
    IDrugs; 2008 Mar; 11(3):189-97. PubMed ID: 18311656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. sigma-1 receptors in major depression and anxiety.
    Kulkarni SK; Dhir A
    Expert Rev Neurother; 2009 Jul; 9(7):1021-34. PubMed ID: 19589051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of GABA in the pathophysiology and treatment of anxiety disorders.
    Nemeroff CB
    Psychopharmacol Bull; 2003; 37(4):133-46. PubMed ID: 15131523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of GABA(B) receptor ligands in drug addiction, anxiety, depression and other CNS disorders.
    Kumar K; Sharma S; Kumar P; Deshmukh R
    Pharmacol Biochem Behav; 2013 Sep; 110():174-84. PubMed ID: 23872369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
    Nothdurfter C; Rammes G; Baghai TC; Schüle C; Schumacher M; Papadopoulos V; Rupprecht R
    J Neuroendocrinol; 2012 Jan; 24(1):82-92. PubMed ID: 21609361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New directions in GABAergic pharmacology of anxiety and depression].
    Kaluev AV; Nutt DD
    Eksp Klin Farmakol; 2004; 67(6):3-7. PubMed ID: 15707004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.
    Krogsgaard-Larsen P; Frølund B; Liljefors T; Ebert B
    Biochem Pharmacol; 2004 Oct; 68(8):1573-80. PubMed ID: 15451401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the GABA-A-benzodiazepine receptor pharmacology.
    Kostowski W
    Pol J Pharmacol; 1995; 47(3):237-46. PubMed ID: 8714756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAergic regulation of auditory sensory gating in low- and high-anxiety rats submitted to a fear conditioning procedure.
    Nobre MJ; Cabral A; Brandão ML
    Neuroscience; 2010 Dec; 171(4):1152-63. PubMed ID: 20937363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.